We examined the effect of angiotensin I (AI), without the effect of angiotensin II (AII) converted from AI, on the weight of the adrenal glands, adrenal corticosterone (B) and adrenal aldosterone under conditions where the reninangiotensin system was suppressed, since a reduction in the size of the adrenal glands is often observed in DOCA/salt hypertensive rats. Sixty male Wistar rats fed on a 1% NaCl solution were divided into 6 groups as follows: a) Salt group: received sesame oil and vehicle, b) Salt+C group: received sesame oil and MK422 (0.14mg/day), an angiotensin converting enzyme inhibitor (CEI), c) DOCA group: received DOCA (30mg/week) and vehicle, d) DOCA+A group: received DOCA and AI (0.5mg/kg/day), e) DOCA+A+ C group: received DOCA and AI with MK422, and f) DOCA+C group: received DOCA and MK422. After 4 weeks, the rats were sacrificed to sample their blood and remove their adrenal glands. There was no significant difference in adrenal B among the groups apart from the DOCA+C group. Adrenal aldosterone was lower in the groups of DOCA/salt hypertensive rats than in the Salt group and Salt+C group. Furthermore, the DOCA+A+C group and DOCA+C group had lower adrenal aldosterone levels than the DOCA group and DOCA+A group. On the other hand, adrenal gland weight in the DOCA+A+C group was similar to that in the Salt group and Salt+C,group, although it was lower in the DOCA group and DOCA+C group than in the Salt group, Salt+C group and DOCA+A+C group. These independently of All in DOCA/salt hypertensive rats.
that the renin-angiotensin system is suppresed in DOCA/salt hypertensive rats (Campbell and Penttinger, 1975) , and that angiotensin II (AII) is a potent stimulator of adrenal corticoid synthesis (Brown et al., 1972; Ganguly et al., 1977; Mason et al., 1977) . The suppression of AII may therefore tend to inhibit the synthesis of cor-ticoids in such rats. However, the mechanisms involved in the reduction in size of the adrenal glands in DOCA/salt hypertensive rats remain obscure. The present study was undertaken to investigate the possible role of angiotensin I (AI) in the reduction in weight of the adrenal glands in DOCA/salt hypertensive rats. There was no significant difference in B. W. in any of the groups before administration of the drugs. Four weeks after administration, the B. W. in the Salt+C group was higher than that in other groups.
Comparison
of blood pressure (B. P.) (Table 1) There was no significant difference in B. P. in any of all the groups before administration of the drugs.
Four weeks after administration, the B. P. in the 4 groups of DOCA/salt hypertensive rats was significantly higher than that in the Salt group and Salt+C group.
of weight of adrenal glands ( Fig. 1) The weight of the adrenal glands was expressed as the weight (mg) 
Discussion
The present findings indicated that intraperitoneal AI administration prevented reduction in the weight of the adrenal glands in DOCA/salt hypertensive rats. Braley et al.(1981) , Douglas et al.(1979) and Hepp et al.(1977) have reported that AI can stimulate aldosterone secretion from isolated rat glomerulosa and bovine fasciculata cells, while Mendelsohn and Kachel (1980) have reported that the stimulatory action of AI on aldosterone and B depended on conversion in vitro to AII, and that All has only low intrinsic activity in corticoid production. In the present study, AI administration in vivo did not stimulate adrenal aldosterone in DOCA/salt hypertensive rats in which the renin-angiotensin system was suppressed. One explanation for this could be that the dose of AI administered was so small that AI was unable to stimulate adrenal aldosterone production, since the plasma AI concentrations in the DOCA/salt hypertensive rats were lower than 10-10M in this study. It has been reported that the threshold for the stimulation of aldosterone and B by AI in vitro is 10-10M (Braley et al., 1981; Douglas et al., 1979; Mendelsohn and Kachel 1980) . However, it remains uncertain whether the stimulatory action of AI on steroidogenesis is dependent on conversion to All or not. Although no significant difference was observed in the PRA and plasma AI in the Salt group and Salt+C group, MK422 was considered to inhibit the conversion from AI to AII, since adrenal aldosterone was significantly reduced by MK422 with and without AI administration in DOCA/salt hypertensive rats (DOCA+A+C group and DOCA+C group). Shier et al.(1989) have reported that the CEI, lisinopril, can reduce the production of aldosterone by adrenal cell cultures by inhibiting adrenal AII. We suspected that chronic feeding on a 1% NaCl solution might have suppressed renin production in both the Salt group and Salt +C group, so accounting for the disappearance of a significant difference between these groups.
The observation that no significant difference in adrenal B occurred except in the DOCA+C group suggests that adrenocorticotropin (ACTH) may not be a factor contributing to the reduction in adrenal aldosterone and the weight of the adrenal glands in DOCA/salt hypertensive rats. Eguchi et al.(1980) found that the CEI, captopril, did not alter the effect of ACTH on the control of aldosterone. Adrenal aldosterone was therefore considered to depend on the plasma and/or adrenal AII in the present study. It is difficult to explain why a decrease in adrenal B occurred in the DOCA+C group. Angeli et al.(1981) reported that the CEI, captopril, did not interfere with ACTH and cortisol in human subjects with hypertension. On the other hand, Petkova et al. (1986) found that captopril caused a signitaneously hypertensive rats (SHR) at 8 months of age, while no decrease was observed in young SHR at 1 month of age. However, they did not discuss the underlying mechanisms involved. The above experimental report did not match with our study in terms of the age and kind of animal used. We have previously reported that chronic MK422 administration did not alter the level of plasma B in Wistar rats (Fukuda et al., 1987) . We suspected therefore that adrenal B could have been reduced when All was suppressed to below some particular concentration, since plasma and/ or adrenal All was considered to be suppressed more strongly in the DOCA+C group than in the other groups. In contrast to the reduction in adrenal aldosterone, AI administration attenuated the reduction in weight of the adrenal glands in DOCA/ salt hypertensive rats (DOCA+A group). Furthermore, AI with MK422 administration in DOCA/salt hypertensive rats (DOCA+ A+C group) gave a similar adrenal gland weight to that in the Salt group and Salt +C group. If All contributed to the prevention of a reduction in the weight of the adrenal glands, the weight of the adrenal glands in the DOCA + A group could have been higher than that in the DOCA+A+ C group in which the plasma AI level was significantly higher than in the other groups of DOCA/salt hypertensive rats. We did not examine the effect of AI on the adrenal medulla, or pathological changes in the adrenal glands following the administration of the drugs to DOCA/salt hypertensive rats. However, it seems unlikely that the Vol.37, No.4 ANGIOTENSIN I PREVENTS ADRENAL WEIGHT LOSS adrenal medulla was suppressed by the administration of DOCA, since we have previously reported an increase in urinary adrenaline excretion in DOCA/salt hypertensive rats, suggesting an increase in adrenal adrenaline production in this animal model (Minato et al., 1990) . A hypotensive action of MK422 was found in DOCA/salt hypertensive rats, although there have been various observations indicating that the CEI, CV-3317 (Inada et al., 1986) , and saralasin, an antagonist of All (Morton et al., 1979) , did not reduce the B. P. in renin-angiotensin independent hypertensive models such as DOCA/salt hypertensive rats.
It has been reported, however, that the hypotensive effect of CEI is due not only to the blockade of angiotensin converting enzyme but also to stimulation of prostaglandin synthesis (Barr et al., 1980) , an increase in kinin (Marks et al., 1980) and a reduction of vasopressin (Igarashi et al., 1985) . Thus, such mechanisms might have induced a decrease in B. P. in the present study.
The above findings suggest that AI can prevent a reduction in the weight of the adrenal glands independently of All in DOCA/salt hypertensive rats. However, details of the mechanisms involved remain obscure. Further investigations are clearly needed.
